CLYM
Climb Bio (CLYM)
NASDAQ
$9.69-$0.13 (-1.34%)
Price as of Oct 16, 2026 7:57 PM EDT
  • $564.0M
    Market Cap
  • 408.81%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
25,000
-92.98%
356,000
+251.49%
-235,000
+91.06%
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
25,000
-92.98%
356,000
+251.49%
-235,000
+91.06%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-46.7M
+229.52%
-14.2M
-8.01%
-15.4M
-41.21%
-26.2M
+18.91%
Depreciation and Amortization Expense
97,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
67.9M
-17.24%
82.0M
+103.65%
40.3M
-10.77%
45.1M
+26.53%
Operating Profit
-67.9M
-17.24%
-82.0M
+103.65%
-40.3M
-10.77%
-45.1M
+26.53%
Interest Income
8.3M
+2.35%
8.1M
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
8.3M
+2.35%
8.1M
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
8.0M
-1.12%
8.1M
+57.54%
5.2M
+4,830.28%
-109,000
-99.08%
Income before Taxes
-67.9M
-17.24%
-82.0M
+103.65%
-40.3M
-10.98%
-45.2M
-13.04%
Income Taxes
0
N/A
0
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
0
-100.00%
180,000
N/A
N/A
N/A
Net Income
-59.9M
-19.01%
-73.9M
+110.42%
-35.1M
-22.38%
-45.2M
-4.71%
Net Income from Continuing Operations Applicable to Common
-59.9M
-19.01%
-73.9M
+110.42%
-35.1M
-22.38%
-45.2M
-13.04%
Basic EPS and Net Income
-0.88
-42.48%
-1.53
+17.69%
-1.30
-24.42%
-1.72
-59.43%
Diluted EPS and Net Income
-0.88
-42.48%
-1.53
+17.69%
-1.30
-24.42%
-1.72
-59.43%
Basic Weighted Average Shares
67.8M
+40.80%
48.2M
+78.47%
27.0M
+2.57%
26.3M
+114.60%
Diluted Weighted Average Shares
67.8M
+40.80%
48.2M
+78.47%
27.0M
+2.57%
26.3M
+114.60%
Balance Sheet
Cash and Cash Equivalents
35.7M
-59.09%
87.2M
-6.32%
93.1M
+113.63%
43.6M
-7.11%
Short-Term Investments
65.4M
+2.68%
63.7M
+365.37%
13.7M
-82.89%
80.0M
-10.69%
Cash and Cash Equivalents and Short-Term Investments
101.1M
-33.02%
150.9M
+41.31%
106.8M
-13.57%
123.6M
-9.46%
Total Current Assets
105.8M
-31.65%
154.9M
+40.47%
110.3M
-17.96%
134.4M
-9.35%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
288,000
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
1.5M
+611.63%
215,000
+1,333.33%
15,000
-88.28%
128,000
+82.86%
Total Assets
167.7M
-22.77%
217.2M
+96.60%
110.5M
-18.17%
135.0M
-22.08%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
7.0M
+41.63%
4.9M
+74.06%
2.8M
-53.53%
6.1M
+1.09%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
285,000
N/A
0
-100.00%
22,000
N/A
0
-100.00%
Total Liabilities
7.3M
+37.00%
5.3M
+84.88%
2.9M
-54.28%
6.3M
+3.96%
Retained Earnings
-289.7M
+26.04%
-229.9M
+47.38%
-156.0M
+29.06%
-120.9M
+59.83%
Total Stockholders Equity
160.5M
-24.26%
211.9M
+96.92%
107.6M
-16.41%
128.7M
-23.02%
Total Shares Outstanding
47.8M
-28.98%
67.3M
+142.80%
27.7M
+4.26%
26.6M
+1.27%
Cash Flow
Cash from Operating Activities
-54.4M
+249.29%
-15.6M
-24.45%
-20.6M
-44.88%
-37.4M
+3.60%
Capital Expenditures
186,000
-96.00%
4.6M
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
2.8M
+102.34%
-121.1M
-275.54%
69.0M
+100.29%
34.4M
+129.96%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
-21,000
-100.02%
130.7M
+15,444.47%
841,000
N/A
0
-100.00%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-328,080.00%
+2,799.97%
-11,313.20%
-158.90%
19,206.38%
N/A
Return on Assets
-31.10%
-31.06%
-45.11%
+57.63%
-28.61%
-2.53%
-29.36%
N/A
Return on Equity
-32.15%
-30.51%
-46.26%
+55.64%
-29.72%
-2.80%
-30.58%
N/A
Revenue Growth
N/A
N/A
-92.98%
-136.97%
251.49%
+376.19%
-91.06%
N/A
Current Ratio
15.16
-51.74%
31.41
-19.30%
38.92
+76.56%
22.04
N/A
Cash Ratio
5.11
-71.12%
17.69
-46.18%
32.87
+359.77%
7.15
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow